Healthy Skepticism Library item: 3388
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
Re: the promotion of Rheopyrine
1986 Apr;
Abstract:
Medimpex markets Rheopyrine, a combination of amidopyrine and phenylbutazone, in Africa for a variety of rheumatological and neurological conditions. Both of these drugs have very serious side effects.
Keywords:
*analysis/Africa/developing countries/Medimpex/Rheopyrine/MaLAM/Medical Lobby for Appropriate Marketing/amidopyrine/phenylbutazone/ quality of information/ safety & risk information/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES